Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: Results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study

Annals of Oncology

Volumn 25, Issue 7, 2014, Pages 1320-1327

  Trillsch, F ^a   Mahner, Sven ^a   Woelber, L ^a   Vettorazzi, E ^a   Reuss, A ^b   Ewald Riegler, N ^c   de Gregorio, N ^d   Fotopoulou, C ^e   Schmalfeldt, B ^f   Burges, A ^g   Hilpert, F ^h   Fehm, T ⁱ   Meier, W ^j   Hillemanns, P ^k   Hanker, L ^l,m   Hasenburg, A ⁿ   Strauss, H G ^o   Hellriegel, M ^p   Wimberger, P ^q,r   Baumann, K ^s   Keyver Paik, M D ^t   Canzler, U ^r   Wollschlaeger, K ^u   Forner, D ^v   Pfisterer, J ^h,w   Schroeder, W ^x   Muenstedt, K ^y   Richter, B ^z   Kommoss, F ^aa   Hauptmann, S ^o,aa   du Bois, A ^ab   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b AGO and Coordinating Center for Clinical Trials   (Germany)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j Children s Hospital   (Germany)

^k HANNOVER MEDICAL SCHOOL   (Germany)

^l UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^m UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁿ UNIVERSITY OF FREIBURG   (Germany)

^o MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^p UNIVERSITY OF GÖTTINGEN   (Germany)

^q UNIVERSITY HOSPITAL ESSEN   (Germany)

^r UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^s UNIVERSITY HOSPITAL MARBURG   (Germany)

^t UNIVERSITY OF BONN   (Germany)

^u UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^v SANA KLINIKUM OFFENBACH   (Germany)

^w STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

^x GYNAEKOLOGICUM Bremen   (Germany)

^y UNIVERSITY HOSPITAL GIESSEN   (Germany)

^z Elblandkliniken Radebeul   (Germany)

^aa Institute of Pathology   (Germany)

^ab KLINIKEN ESSEN MITTE   (Germany)

more..

Author keywords

Borderline ovarian tumour; Fertility preservation; Malignant transformation; Recurrence; Surgical treatment

Indexed keywords

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; BORDERLINE OVARIAN TUMOR; CANCER PROGNOSIS; CANCER STAGING; CARCINOMATOUS PERITONITIS; CLINICAL FEATURE; CONSULTATION; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FERTILITY PRESERVATION; FOLLOW UP; GERMANY; GYNECOLOGIC SURGERY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LAPAROTOMY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; OVARY TUMOR; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; TUMOR RECURRENCE; MIDDLE AGED; OVARIAN NEOPLASMS; PATHOLOGY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903703659     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu119     Document Type: Article

References (22)

1. Skirnisdottir I, Garmo H, Wilander E et al. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008; 123: 1897-1901.
2. Trope C, Kaern J. Management of borderline tumors of the ovary: state of the art. Semin Oncol 1998; 25: 372-380.
3. Heintz AP, Odicino F, Maisonneuve P et al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95(Suppl 1): S161-S192.
4. Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press 2003.
5. Tang A, Kondalsamy-Chennakesavan S, Ngan H et al. Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801). Gynecol Oncol 2012; 126: 36-40.
6. Du Bois A, Ewald-Riegler N, du Bois O et al. Borderline tumors of the ovary-a systematic review [German]. Geburtsh Frauenheilk 2009; 69: 807-833.
7. Sherman ME, Mink PJ, Curtis R et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer 2004; 100: 1045-1052.
8. Trillsch F, Mahner S, Ruetzel J et al. Clinical management of borderline ovarian tumors. Expert Rev Anticancer Ther 2010; 10: 1115-1124.
9. du Bois A, Ewald-Riegler N, de Gregorio N et al. Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynakologische Onkologie (AGO) Study Group. Eur J Cancer 2013; 49: 1905-1914.
10. Tavassoli FA, Devilee P, International Agency for Research on Cancer. World Health Organization. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IAPS Press 2003.
11. Deutsche Krebsgesellschaft DK, AWMF. S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Langversion 1.0 2013; http://leitlinien programm-onkologie.de/Leitlinien.7.0.html (24 March 2014, date last accessed). AWMF Registrierungsnummer: 032-035OL.
12. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376: 911-921.
13. Cadron I, Leunen K, Van Gorp T et al. Management of borderline ovarian neoplasms. J Clin Oncol 2007; 25: 2928-2937.
14. Morice P, Uzan C, Fauvet R et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol 2012; 13: e103-e115.
15. Kurman RJ, Shih Ie M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011; 42: 918-931.
16. Trillsch F, Aberle J, Regier M et al. Lost in effusion. Lancet 2012; 380: 620.
17. May T, Virtanen C, Sharma M et al. Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary. Gynecol Oncol 2010; 117: 9-17.
18. Bouchardy C, Rapiti E, Blagojevic S et al. Older female cancer patients:importance, causes, and consequences of undertreatment. J Clin Oncol 2007; 25: 1858-1869.
19. Farley J, Smith LM, Darcy KM et al. Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study. Gynecol Oncol 2011; 121: 395-401.
20. Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008; 27: 151-160.
21. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010; 34: 433-443.
22. Fischerova D, Zikan M, Dundr P et al. Diagnosis, treatment, and follow-up of borderline ovarian tumors. Oncologist 2012; 17: 1515-1533.